SCHEMBL16334267

SCHEMBL16334267

Brc1cccc(SC2CCCC2)n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.46
CYP1A2 P05177 1/20 0.46
KMT2A Q03164 1/20 0.46
HTR1A P08908 2/20 0.40
DRD2 P14416 2/20 0.40
HTR2A P28223 2/20 0.40
HTR7 P34969 2/20 0.40
FFAR4 Q5NUL3 2/20 0.40
PDGFRB P09619 1/20 0.36
PDGFRA P16234 1/20 0.36
ALDH1A1 P00352 2/20 0.35
MAPK1 P28482 1/20 0.33
MAOA P21397 3/20 0.33
MAOB P27338 3/20 0.33
VCP P55072 3/20 0.32
LMNA P02545 1/20 0.31
MAPT P10636 1/20 0.31
HPGD P15428 1/20 0.31
HIF1A Q16665 1/20 0.31
TXN P10599 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16334270 0.96 MEN1 (0.46) MEN1CYP1A2KMT2AHTR1ADRD2
SCHEMBL16333873 0.78 MEN1 (0.73) MEN1CYP1A2KMT2AHTR1ADRD2
SCHEMBL16334124 0.74 MEN1 (0.73) MEN1CYP1A2KMT2AFFAR4PDGFRB
SCHEMBL15668751 0.74 KMT2A (0.43) MEN1CYP1A2KMT2AHTR1ADRD2
SCHEMBL15668901 0.74 MEN1 (0.46) MEN1CYP1A2KMT2AHTR1ADRD2
SCHEMBL21613118 0.73 MEN1 (0.42) MEN1CYP1A2KMT2AFFAR4PDGFRB
SCHEMBL15668714 0.73 KMT2A (0.42) MEN1CYP1A2KMT2AHTR1ADRD2
SCHEMBL15669054 0.73 MEN1 (0.45) MEN1CYP1A2KMT2AHTR1ADRD2
SCHEMBL15668848 0.70 MEN1 (0.43) MEN1CYP1A2KMT2AHTR1ADRD2
SCHEMBL15668851 0.70 MEN1 (0.46) MEN1CYP1A2KMT2AHTR1ADRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105392777-B Biaryl derivatives as GPR120 agonists 株式会社LG化学 2020-09-22 CN disclosed
EP-3013796-B9 BIARYL DERIVATIVES AS GPR120 AGONISTS LG CHEMICAL LTD (KR) 2020-07-01 EP disclosed
EP-3628661-A1 BIARYL DERIVATIVES AS GPR120 AGONISTS LG CHEM, LTD. (KR) 2020-04-01 EP disclosed
US-10221138-B2 Biaryl derivatives as GPR120 agonists LG CHEM, LTD. (KR) 2019-03-05 US disclosed
US-20160168096-A1 BIARYL DERIVATIVES AS GPR120 AGONISTS LG LIFE SCIENCES LTD. (KR) 2016-06-16 US disclosed
EP-3013796-A1 BIARYL DERIVATIVES AS GPR120 AGONISTS LG Life Sciences Ltd. (KR) 2016-05-04 EP disclosed
CN-105392777-A Biaryl derivatives as GRP120 agonists LG LIFE SCIENCES LTD 2016-03-09 CN disclosed
WO-2014209034-A1 BIARYL DERIVATIVES AS GPR120 AGONISTS LG LIFE SCIENCES LTD. (KR) 2014-12-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160168096-A1 BIARYL DERIVATIVES AS GPR120 AGONISTS GPR119, GLP1R, GIPR MEN1 2310/4885CYP1A2 594/4885KMT2A 2384/4885
US-10221138-B2 Biaryl derivatives as GPR120 agonists GPR119, GLP1R, GIPR MEN1 2310/4885CYP1A2 594/4885KMT2A 2384/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.